Rigel Pharmaceuticals, Inc. · NASDAQ:RIGL

Armistice Capital, LLC reported a 6.93% stake in Rigel Pharmaceuticals, Inc. (Schedule 13G)

Event Mar 31, 2026 · Filed May 15, 2026

Armistice Capital, LLC reported a 6.93% stake in Rigel Pharmaceuticals, Inc., 1,280,000 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G).

Stake
6.93%
Shares
1,280,000
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Armistice Capital, LLC6.93%1,280,000
Steven Boyd6.93%1,280,000

Source

View original at SEC

Related